Literature DB >> 620493

Intracellular free amino acids in muscle tissue of patients with chronic uraemia: effect of peritoneal dialysis and infusion of essential amino acids.

J Bergström, P Fürst, L O Norée, E Vinnars.   

Abstract

1. Free amino acids were determined in the plasma and in the muscle tissue of 14 patients with chronic uraemia; eight were not on dialysis and six were having regular peritoneal dialysis. The concentration of each amino acid in muscle water was calculated with the chloride method. 2. In both groups of patients there were low intracellular concentrations of threonine, valine, tyrosine and carnosine, and high glycine/valine and phenylalanine/tyrosine ratios. Both groups of patients had increased amounts of 1- and 3-methyl-histidine in plasma and in muscle water. 3. The non-dialysed patients had low intracellular concentrations of lysine, and the dialysed patients had high intracellular concentrations of lysine, isoleucine, leucine and of some of the non-essential amino acids. 4. After peritoneal dialysis for 22 h, the plasma concentration of several amino acids decreased but the intracellular concentrations of most amino acids did not change significantly. 5. Intravenous administration of essential amino acids and histidine during the last 4 h of dialysis increased in muscle the total free amino acids, the ratio of essential to non-essential amino acids and the valine and phenylalanine concentrations. 6. The results demonstrated that the plasma and muscle concentrations of several amino acids are grossly abnormal in chronic uraemia. Non-dialysed and dialysed patients exhibit important differences, especially in the intracellular amino acid patterns. Infusion of essential amino acids may result in enhancement of protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620493     DOI: 10.1042/cs0540051

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  9 in total

1.  Long-term effect of amino-acid dialysis solution in children on continuous ambulatory peritoneal dialysis.

Authors:  A Canepa; F Perfumo; A Carrea; F Giallongo; E Verrina; A Cantaluppi; R Gusmano
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Amino acids and the kidney.

Authors:  G A Young
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

Review 3.  Recent advances in the pathogenesis and nutritional treatment of chronic uremia.

Authors:  P Fürst; A Alvestrand; J Bergström
Journal:  Z Ernahrungswiss       Date:  1982-09

4.  Muscle and plasma amino acids after injury: hypocaloric glucose vs. amino acid infusion.

Authors:  J Askanazi; P Furst; C B Michelsen; D H Elwyn; E Vinnars; F E Gump; F E Stinchfield; J M Kinney
Journal:  Ann Surg       Date:  1980-04       Impact factor: 12.969

5.  Muscle and plasma amino acids following injury. Influence of intercurrent infection.

Authors:  J Askanazi; Y A Carpentier; C B Michelsen; D H Elwyn; P Furst; L R Kantrowitz; F E Gump; J M Kinney
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

6.  Carnosine and anserine concentrations in the quadriceps femoris muscle of healthy humans.

Authors:  A F Mannion; P M Jakeman; M Dunnett; R C Harris; P L Willan
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

7.  Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis.

Authors:  D H Kim; D H Yang; S Y Hong
Journal:  Korean J Intern Med       Date:  1998-02       Impact factor: 2.884

8.  Enhanced glutamine utilization mediated by SLC1A5 and GPT2 is an essential metabolic feature of colorectal signet ring cell carcinoma with therapeutic potential.

Authors:  Renjie Wang; Wenqiang Xiang; Ye Xu; Lingyu Han; Qingguo Li; Weixing Dai; Guoxiang Cai
Journal:  Ann Transl Med       Date:  2020-03

9.  The effect of dialysis membrane flux on amino acid loss in hemodialysis patients.

Authors:  Hyo Wook Gil; Jong Oh Yang; Eun Young Lee; Eun Mi Lee; Jong Soon Choi; Sae Yong Hong
Journal:  J Korean Med Sci       Date:  2007-08       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.